NCT01287858View on ClinicalTrials.gov

Study to Assess Safety, Tolerability, and Pharmacokinetics of Oral Doses for AC430 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Rheumatoid Arthritis
Interventions
DRUG

AC430

Healthy volunteers will either receive AC430 or placebo.

Trial Locations (1)

53718

Covance Clinical Research Unit, Madison

Sponsors

Lead Sponsor

Daiichi Sankyo
All Listed Sponsors
lead

Daiichi Sankyo

INDUSTRY